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ABSTRACT
Ovarian granulosa cell tumors (GCTs) represent 3%–5% of
all ovarian malignancies. Treatments have limited proven
efficacy and biologically targeted treatment is lacking. The aim
of this study was to investigate the role of Notch signaling in the
proliferation, steroidogenesis, apoptosis, and phosphatidylinosi-
tol 3-kinase (PI3K)/AKT pathway in a FOXL2-mutated granulosa
tumor cell line (KGN) representative of the adult form of GCTs.
When Notch signaling is initiated, the receptors expose a
cleavage site in the extracellular domain to the metalloprotei-
nase TACE and, following this cleavage, Notch undergoes
another cleavage mediated by the presenilin-gamma-secretase
complex. To achieve our goal, DAPT, an inhibitor of the gamma-
secretase complex, was used to investigate the role of the Notch
system in parameters associated with cell growth and death,
using a human granulosa cell tumor line (KGN) as an
experimental model. We observed that JAGGED1, DLL4,
NOTCH1, and NOTCH4 were highly expressed in KGN cells
as compared to granulosa-lutein cells obtained from assisted
reproductive techniques patients. The proliferation and viability
of KGN cells, as well as progesterone and estradiol production,
decreased in the presence of 20 lM DAPT. Apoptotic
parameters like PARP and caspase 8 cleavages, BAX, and BCLXs
increased in KGN cells cultured with DAPT, whereas others such
as BCL2, BCLXl, FAS, and FAS ligand did not change. AKT
phosphorylation decreased and PTEN protein increased when
Notch signaling was inhibited in KGN cells. We conclude that
the Notch system acts as a survival pathway in KGN cells, and
might be interacting with the PI3K/AKT pathway.
apoptosis, KGN cells, Notch system, PI3K/AKT signaling
INTRODUCTION
Ovarian granulosa cell tumors (GCTs) belong to sex cord-
stromal tumors and represent 3%–5% of all ovarian malignan-
cies [1]. These tumors arise from granulosa cells and their
malignant potential is due to their tendency to recur and
metastasize. The probability of recurrence in GCT patients is
rather high (35%), and 80% of those with recurrent disease will
die from it. Although GCTs are comprised of cells different
from those of epithelial tumors, they are often treated the same,
simply because GCTs are rare and there is little information
available. Although these tumors contain both granulosa and
theca cells, the malignant part arises from the granulosa
component. GCTs are categorized into two distinct subtypes:
the juvenile and the adult form. Little is known about the
pathogenesis of ovarian GCTs. However, Shah et al. [2] have
recently reported a somatic mutation in the FOXL2 gene
(C402G; Cys134Trp), specifically present in 97% of adult
GCTs. The presence of this mutation was later confirmed in
several other publications [3–7], and subsequent studies
confirmed its presence in adult GCTs and its absence in
juvenile GCTs and other human malignancies [5, 8–11].
However, treatments have limited proven efficacy and
biologically targeted treatment modalities are lacking.
The Notch system is an evolutionary conserved pathway
involved in key developmental processes. In mammals, the
Notch family of proteins consists of four receptors (NOTCH 1–
4) and five ligands (JAGGED 1 and 2 and DELTA-like 1, 3, 4)
expressed on the cell surface. When Notch signaling is
initiated, the receptors expose a cleavage site in the
extracellular domain to the metalloproteinase TACE and,
following this cleavage, Notch undergoes another cleavage
mediated by the presenilin-c-secretase complex. This results in
the release of the active intracellular domain, which translo-
cates to the nucleus [12] and exerts pleiotropic effects by
initiating a transcriptional cascade [13]. The Notch pathway is
also involved in vascular maintenance and remodeling and is a
key participant in tumor angiogenesis [14].
Several lines of evidence demonstrate that Notch is involved
in several human cancers. In particular, high expression of
Notch1 and Jagged1 in breast cancer is linked to poor survival
rates, and Jagged 1 is highly expressed in metastatic prostate
cancer as compared to localized or benign prostatic tissue [15–
17].
In particular, in ovarian cancer, the Notch signaling pathway
has been found altered in 22% of 316 cases of high-grade
serous ovarian adenocarcinomas analyzed [18]. Moreover,
Jagged1 and Dll4 play important roles in tumor and endothelial
compartments of ovarian cancer mouse models [19, 20].
Nevertheless, the function of this novel Notch system in the
adult form of GCTs remains unknown.
The phosphatidylinositol 3-kinase (PI3K)/AKT signal
transduction pathway plays a critical role in cell survival
through suppression of apoptosis in various types of human
cancers, including ovarian cancer [21–24]. PI3K is an activator
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of AKT and has been proposed as a putative oncogen in
ovarian cancer, because its activation has been associated with
aggressiveness of the tumor behavior and decreased survival
[25, 26]. In addition, different reports have demonstrated the
interaction between Notch signaling and PI3K/AKT pathways
in breast cancer cells and prostate cancer cells [27, 28].
Based on these antecedents about the participation of Notch
signaling in the behavior of a wide range of human cancers,
including epithelial ovarian cancer, we speculated that this
system might be involved in the regulation of cell survival and
apoptosis in GCTs. To test this hypothesis, we used a granulosa
tumor cell line (KGN) representative of the adult form of GCTs
[5], and examined the expression of some Notch members and
whether the inhibition of Notch signaling affects proliferation,
steroidogenesis, and apoptotic parameters. Because it is known
that the PI3K/AKT pathway is involved in ovarian cancer, we
studied a possible interaction between this intracellular
pathway and Notch signaling.
MATERIALS AND METHODS
Reagents
Antibodies against NOTCH1 (sc-6014-R), NOTCH4 (sc-9170), JAGGED1
(sc-8303), DLL4 (sc-28915), PARP (sc-7150), BAX (sc-493), BCLX (SC-
634), FAS (sc-715), FAS ligand (FASL) (sc-956), Caspase 8 (sc-7890),
phospho-AKT (sc-7985) and actin B (sc-1616) were purchased from Santa
Cruz Biotechnology, Inc. AKT (9272) antibody was from Abcam and
monoclonal BCL2 (887) antibody was from Dako. Antibody against PTEN
(phosphatase and tensin homolog) was purchased from Millipore, anti-rabbit
secondary antibody (A-9414) from Sigma-Aldrich, and anti-mouse IgG
horseradish peroxidase conjugate (HAF007) from R&D Systems. All other
chemicals were of reagent grade and were obtained from standard commercial
sources.
Culture of KGN and Obtaining of Human
Granulosa-Lutein Cells
The study was approved by the Research Ethics Committee of the Instituto
de Biologı´a y Medicina Experimental, Buenos Aires, Argentina. The tumor cell
line (KGN) was kindly provided by Dr. H. Nawata, Kyushu University, Japan
[29]. For the different experiment techniques, cells were cultured in Dulbecco
modified Eagle medium (DMEM):F12 (1:1 vol/vol; Sigma) supplemented with
10% fetal bovine serum (FBS; PAA Laboratories), fungizone (250 lg/ml), and
gentamicin (10 mg/ml; Life Technologies, Inc.) with 5% CO
2
–95% air at 378C.
KGN cells were characterized as a malignant tumor model of the adult form of
GCTs [30].
For comparative purposes human granulosa-lutein cells (hGCs) were
obtained from patients subjected to assisted reproductive techniques (ART).
Written informed consent was obtained from all the patients before recruitment,
and patients with pelvic pathologies such as endometriosis, uterine fibroids, or
pelvic inflammatory disease were excluded from the study. Follicular fluid was
collected during oocyte retrieval from nine patients attending PREGNA
Institute of Reproductive Medicine (Argentina) for male and female infertility
treatment, as previously described [31, 32]. Briefly, follicular aspirates of each
patient collected during oocyte retrieval were centrifuged at 4003g for 10 min.
After removing the supernatant, the layers of hGCs with the red blood cell
pellet were resuspended in 2 ml of DMEM:F12 (1:1 vol/vol) containing 10 mM
HEPES supplemented with fungizone (250 lg/ml) and gentamicin (10 mg/ml;
Life Technologies, Inc.) in a sterile 50-ml centrifuge tube. The resuspended
pellet was layered carefully on Percoll cushion (density¼ 1.085, 3 ml Percoll/
ml cell suspension; Sigma-Aldrich) in 15-ml sterile tubes and centrifuged at
600 3 g for 30 min. Granulosa-lutein cells were aspirated from the interface,
resuspended, and observed under an optic microscope. Finally, the pellet was
stored at 708C for protein extraction.
For the study of apoptotic parameters in KGN cells, 23 105 cells per well
were seeded in six-well tissue culture plates maintained in DMEM containing
10% FBS. After 24 h of culture, the medium was removed and fresh medium
containing 2% FBS with or without DAPT (N-[N-(3,5-difluorophenacetyl-L-
alanyl)]-S-phenylglycine t-butyl ester; Sigma-Aldrich) 20 lM was added for an
additional 48 h. When cells were incubated in the absence of DAPT, 0.05%
dimethyl sulfoxide (DMSO) was added to the medium. Finally, cells were
stored at 208C for protein extraction.
Proliferation Assay
To evaluate the role of the Notch pathway in the proliferation of granulosa
cell tumor line, KGN cells were incubated for 48 h either in the presence of
DAPT, an inhibitor of the c-secretase complex, or in the presence of its diluent,
0.05% DMSO. The proliferation was evaluated with increasing DAPT
concentrations (10, 20, and 30 lM) that have been demonstrated to be
nontoxic in cultured cells [28, 33, 34]. For the assay, tritiated thymidine (0.4
lCi/well, final specific activity 1.2 Ci/mmol; NE027E; Perkin Elmer) was
added to the culture 24 h after the stimulus. After an additional 24 h, cells (13
105/well in a 96-well plate) were harvested by vacuum aspiration onto glass
fiber filters, which were washed (5 sec/wash) and dried with 1 volume of
ethanol using a multiwell harvester [35]. Filters were allowed to dry and then
transferred to vials containing scintillation cocktail (Optiphase HiSafe 3
scintillation liquid; Wallac). Radioactivity was counted in a scintillation counter
(Tri-Carb 1600TR; efficiency 66.29%; Packard).
Cell Viability
The number of viable cells following treatment with either different
concentrations of DAPT or the PI3K inhibitor LY294002 was assessed using
the Cell Titer 96AQueous One solution cell proliferation assay (MTS assay;
Promega Corp.). Cells (1 3 104/well) were seeded in a 96-well culture plate,
maintained for 24 h in DMEM containing 10% FBS, and incubated for 48 h in
DMEM:F12 containing 2% FBS with DAPT (10, 20, and 30 lM) or LY294002
(5, 15, and 25 lM). A volume of 20 ll of 2-(40,50-dimethyl-20-thiazolyl)-3-(4 00-
sulfophenyl) (MTS) solution was added to each well; the MTS tetrazolium
compound was reduced by reduced nicotinamide adenine dinucleotide
phosphate or reduced nicotinamide adenine dinucleotide produced by
dehydrogenase enzymes in metabolically active cells into a colored, soluble
formazan product. The plate was kept for 3 h in a CO
2
incubator, and the
absorbance at 490 nm was recorded with a 96-well plate ELISA reader
(Thermo Scientific).
Radioimmunoassay for Progesterone and Estradiol
KGN cells (1 3 105 cells/well) were precultured in 24-well plates with
DMEM:F12 containing 10% FBS for 48 h. The medium was changed to
DMEM:F12 containing 2% FBS and 100 nM of androstenedione (a substrate
for P450arom), and either DMSO 0.05% or DAPT 20 lM was added to the
culture medium. After 48 h culture, the supernatant of the culture medium was
collected for the determination of steroid levels and stored at 208C until the
assay. Progesterone and estradiol were measured using specific antibodies
supplied by Dr. G.D. Niswender (Animal Reproduction and Biotechnology
Laboratory, Colorado State University, Fort Collins, CO). Under these
conditions, the intra-assay and interassay variations were 8.0% and 14.2%
for progesterone and 7.2% and 12.5% for estradiol, respectively. The detection
limit of the radioimmunoassay (RIA) for both steroids was 25 pg.
Western Blot Analysis
For Western blot analysis, hGCs and KGN cells were lysed in
homogenization buffer containing 20 mM Tris-HCl pH 8, 137 mM NaCl,
1% Nonidet P-40, and 10% glycerol, supplemented with protease inhibitors
(0.5 mM phenylmethylsulfonyl fluoride, 0.025 mM N-CBZ-L-phenylalanine
chloromethyl ketone, 0.025 mM N-p-tosyl-lysine chloromethyl ketone, and
0.025 mM L-1-tosylamide-2-phenyl-ethylchloromethyl ketone) and phospha-
tase inhibitors (25 mM sodium fluoride, 0.2 mM sodium orthovanadate, and 10
mM b-glycerophosphate). Samples were centrifuged at 48C for 10 min at
10 0003g and the resulting pellets were discarded. Protein concentration in the
supernatant was measured by the Bradford assay. After boiling for 5 min, 20 lg
of protein was applied to an SDS-polyacrylamide gel (12%–15%) and
electrophoresis was performed at 25 mA for 1.5 h. The resolved proteins were
transferred for 2 h onto nitrocellulose membranes. The blot was preincubated in
blocking buffer (5% nonfat milk, 0.05% Tween-20 in 20 mM TBS pH 8.0) for
1 h at room temperature and incubated with appropriate primary antibodies
(NOTCH1 [1:400], NOTCH4 [1:400], JAGGED1 [1:200], PARP [1:200],
BAX [1:200], BCL2 [1:200], BCLX [1:200], FAS [1:200], FASL [1:100],
caspase 8 [1:200], AKT [1:5000], p-AKT [1:400], and PTEN [1:1000]) in
blocking buffer overnight at 48C. The blots were then incubated with anti-rabbit
or anti-mouse secondary antibodies conjugated with horseradish peroxidase
(1:1000) and finally detected by chemiluminescence and autoradiography using
x-ray film. Protein loading was normalized by reprobing the same blots with
antibody against actin B band.
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Data Analysis
Statistical analysis was carried out using GraphPad Prism software. All
experiments were performed at least three times and the conditions were
performed in triplicate.
Experiments were analyzed with Student t-test when two variables were
involved or with one-way ANOVA following Tukey or Dunnett as posttest
when three or more variables were concerned.
Data are expressed as means 6 SEM of pooled results obtained from
different independent experiments. Representative gels are shown in the
figures. Values of P , 0.05 were considered significant.
RESULTS
Analysis of JAGGED1, DLL4, NOTCH1, and NOTCH4
Expression in hGCs and KGN Cells
The expression of JAGGED1, DLL4, NOTCH1, and
NOTCH4 in KGN cells was studied by Western blot. We
used hGCs obtained from patients subjected to ART and KGN
cells to compare the levels of expression of these members.
Tumor cells showed a significant higher expression of
JAGGED 1 (0.16 6 0.03 arbitrary units) than hGCs (0.03 6
0.02, arbitrary units P , 0.001). Similar results were obtained
for NOTCH1 and NOTCH4 (NOTCH1, KGN 0.18 6 0.002
vs. hGCs 0.06 6 0.02 arbitrary units, P , 0.05; NOTCH4,
KGN 0.64 6 0.05 vs. hGCs 0.34 6 0.02 arbitrary units, P ,
0.001). The ligand DLL4 was observed in KGN cells but was
not detected in hGCs (Fig. 1).
Effects of DAPT on KGN Cell Proliferation
To study the role of the Notch system in granulosa tumor
cells proliferation, we used DAPT, an inhibitor of the c-
secretase complex. When KGN cells were incubated for 48 h in
the presence of increasing concentrations of DAPT (10, 20, and
30 lM), cell proliferation decreased, 20 lM being the lowest
concentration (34% of decrease) at which we detected a
significant difference in comparison to controls (no addition of
DAPT) (control 1989 6 42, DAPT 10 lM 1852 6 104, DAPT
20 lM 1317 6 40, DAPT 30 lM 937 6 131 cpm, P , 0.01;
Fig. 2A). Similar results were obtained when the MTS assay
was performed using the same concentrations of Notch
inhibitor (Fig. 2B). For this reason, we chose 20 lM as the
FIG. 1. Expression of JAGGED1, DLL4, NOTCH1, and NOTCH4 was assessed by Western blot using protein extracts of KGN cells (n¼ 10) and hGCs
obtained from follicular fluid of women subjected to ART (n¼ 9). The hGCs and KGN cells were lysed in homogenization buffer, protein concentration
was determined, and 20 lg was applied to a SDS-polyacrylamide gel. Representative bands are shown. Values are expressed as mean6 SEM. *Indicates a
value significantly different, P , 0.05.
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appropriate concentration to perform the subsequent experi-
ments.
Effect of Notch Inhibition on KGN Cell Steroidogenesis
Progesterone and estradiol levels in culture medium of KGN
cells were determined by RIA. We observed a significant
decrease in the culture medium levels of progesterone in KGN
cells cultured in the presence of DAPT 20 lM for 48 h (control
0.72 6 0.08 vs. DAPT 0.46 6 0.07 ng/ml, P , 0.05) as well
as in the levels of estradiol (control 10.85 6 0.80 vs. DAPT
6.82 6 0.35 ng/ml, P , 0.0001) compared to control
conditions (Fig. 2, C and D).
Notch Involvement in the Apoptotic Pathway of KGN Cells
To study the participation of Notch signaling in apoptotic
parameters of KGN cells, we determined the levels of the
cleaved fragment of PARP protein in KGN cells incubated with
DAPT. Full-length PARP is 113 kDa and, in the final step of
apoptosis, it is cleaved by caspase 3, generating an 89-kDa
fragment [36]. Interestingly, we observed a significant increase
in the PARP cleaved fragment in cells incubated for 48 h with
the Notch inhibitor compared to control cells (control 0.04 6
0.01 vs. DAPT 0.10 6 0.02 arbitrary units, P , 0.05; Fig. 3A).
Contribution of Mitochondrial Proteins in
DAPT-Induced Apoptosis
We observed an increase in the proapoptotic proteins BAX
(control 2.29 6 0.20 vs. DAPT 3.27 6 0.25 arbitrary units, P
, 0.01) and BCLXs (control 5.0 6 0.98 vs. DAPT 9.26 6
0.83 arbitrary units, P , 0.05) when Notch activation was
inhibited with DAPT in KGN cells (Fig. 3, B and C). However,
when we analyzed the antiapoptotic proteins BCL2 and BCLXl
in KGN cells in the presence of DAPT, we detected no
significant differences compared to controls (BCL2: control
21.55 6 1.46 vs. DAPT 20.18 6 2.62 arbitrary units; BCLXl:
control 23.28 6 1.56 vs. DAPT 29.71 6 3.36 arbitrary units;
Fig. 3, B and C). Therefore, the balance between BAX/BCL2
and BCLXs/BCLXl was increased in KGN cells after the
inhibition of Notch activation (P , 0.05; Fig. 3, B and C).
FIG. 2. Notch participation in KGN cell proliferation and steroidogenesis. KGN cell proliferation was determined by [3H] thymidine incorporation assay
(A) [35] and cell viability was assessed by MTS assay (B) by following the manufacturer’s instructions. Cells were incubated for 48 h in the presence of
different concentrations of DAPT (10, 20, and 30 lM). Different letters indicate significant differences compared to the control condition (absence of
DAPT). a versus b, P, 0.01. Levels of progesterone (C) and estradiol (D) in culture medium of KGN cells incubated with DAPT 20 lM were determined by
RIA. Values are shown as mean 6 SEM of ng/ml of corresponding steroid in culture medium determined in at least three independent experiments.
*Indicates significant differences with P , 0.05 and P , 0.0001 for progesterone and estradiol, respectively.
"
FIG. 3. Effect of Notch inhibition on apoptotic parameters of KGN cells. Different proteins associated with apoptotic processes were assessed by Western
blot in KGN cells treated with 20 lM of DAPT. A) Densitometric quantification of the cleaved fragment of PARP protein. B and C) Quantification of BAX,
BCL2, BCLXs, and BCLXl and the ratio between these proteins. D) FAS and FASL proteins belonging to the death-receptor pathway. E) The densitometric
quantification of the cleaved fragment of caspase 8 after being activated by death receptors. *Indicates significant differences between control and DAPT
incubation of KGN cells with P , 0.05. All incubations were performed at least three times.
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Involvement of Extrinsic Pathway Proteins in DAPT-Induced
Apoptosis
The levels of FASL and FAS in KGN cells incubated with
DAPT were not significantly different from those in control
cells (FASL: control 0.94 6 0.12 vs. DAPT 1.13 6 0.10
arbitrary units; FAS: control 1.35 6 0.19 vs. DAPT 1.34 6
0.14 arbitrary units; Fig. 3D). However, the active fragment of
caspase 8 increased significantly in the presence of DAPT
(control 0.55 6 0.05 vs. DAPT 0.90 6 0.15 arbitrary units;
Fig. 3E).
Effect of Notch Inhibition on the PI3K/AKT
Intracellular Pathway
To elucidate whether the PI3K/AKT pathway plays a role in
KGN cell viability, we performed an MTS assay in the
presence of LY294002, a PI3K inhibitor. As expected, this
inhibitor decreased the percentage of viability of KGN cells.
The decrease was 33% at 15 lM of LY294002, the lowest
concentration at which we detected significant differences (data
not shown). When we analyzed the levels of AKT phosphor-
ylation in KGN cells in the presence of DAPT to investigate a
possible interaction between these two pathways, we observed
a significant decrease in the phospho-AKT/total AKT ratio in
KGN cells incubated with the Notch inhibitor compared to
control conditions (control 0.55 6 0.13 vs. DAPT 0.16 6 0.02
arbitrary units, P , 0.05; Fig. 4A). Also, PTEN, the protein
responsible for the dephosphorylation of the second messenger
phosphatidylinositol 3,4,5-triphosphate, showed a marked
increase in the presence of DAPT (control 0.03 6 0.004 vs.
DAPT 0.09 6 0.01 arbitrary units; Fig. 4B).
DISCUSSION
The key findings of our study are the survival role of Notch
in KGN, a granulosa tumor cell line representative of the adult
form of GCTs, and the high expression of some Notch
members in this cell line compared to hGCs from ART
patients. We demonstrated for the first time that Notch
inhibition decreases cell proliferation and steroidogenesis and
increases several apoptotic markers in granulosa tumor cells.
We also showed that the Notch pathway might crosstalk with
PI3K/AKT signaling in this cell type.
The Notch system is highly pleiotropic and its effects have
been demonstrated to be context dependent [13]. Members of
this system have been associated with different types of tumors,
and the relationship between some members of this system and
epithelial ovarian cancer has been studied, but no information
is available on GCTs. Choi et al. showed that JAGGED1
promotes proliferation and dissemination of epithelial ovarian
cancer cells [37]. Hu et al. associated DLL4 with worse overall
survival and described it as a proliferation- and angiogenesis-
promoting factor in epithelial ovarian tumor cells and tumor-
associated endothelial cells [20]. Similarly, JAGGED1 pro-
motes proliferation in epithelial ovarian cancer cell lines and is
related to taxane resistance. In the present study, we found a
differential expression of JAGGED1 and NOTCH1 and 4
receptors between KGN cells and hGCs obtained from ART
patients. More studies are needed to demonstrate that Notch
members would be potential therapeutic targets for this type of
tumors. KGN cells might exhibit steroidogenesis similar to
normal hGCs; however, they are likely to differ from normal
granulosa cells in their proliferative potential because KGN is a
tumor-derived cell line [38]. Also, hGCs are luteinized
granulosa cells, whereas KGN cells seem to be close to an
immature granulosa cell developmental stage [30]. However,
right now, hGCs are the best available normal cells that can be
used for comparison purposes.
Because this finding stimulated us to continue with the
study of the Notch system in a granulosa tumor cell line, we
used a c-secretase complex inhibitor (DAPT) to inhibit Notch
activation in KGN cells. Gamma-secretase inhibitors have been
shown to be potent inhibitors of the Notch signaling pathway.
In particular, DAPT has been widely used to perform studies in
different types of tumor cell lines such as endometrial cells,
breast cancer cells, gastric cancer cells, and some animal
models [39–41]. In this study, the inhibition of the Notch
system decreased proliferation and viability of the granulosa
tumor cell line. This result agrees with other studies performed
in tumor cell lines of different origins [33, 42, 43]. In cells of
renal carcinoma using small interfering RNA (siRNA)
targeting the different Notch receptors, it was established that
the Notch promoting effect on proliferation was attributable to
NOTCH1 [42]. More recently, in prostate cancer cells, Wang et
al. demonstrated that down-regulation of NOTCH1 inhibits cell
growth and induces apoptosis [28]. More precisely, in
FIG. 4. Notch and PI3K/AKT signaling pathway. A) Levels of phosphor-
ylated and total AKT. B) Levels of PTEN protein determined by Western
blot in protein extracts of KGN cells incubated for 48 h in the presence or
absence of 20 lM of DAPT. The ratio between phosphorylated and total
AKT is shown in the graph. *P , 0.05.
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epithelial ovarian cancer cell lines, the down-regulation of
JAGGED1 expression affected cell viability and induced
apoptosis [19]. However, Notch opposing effects in tumor
cells have also been described [13]. Regarding cell cycle-
related proteins, it is known that the Notch intracellular domain
translocates into the nucleus, where it forms a complex with the
members of the CBF 1/Su (H)/Lag 1 transcription factor family
[12], and this complex mediates the transcription of target
genes such as Hes-1, Hey, cyclin D, and p21waf1/cip1 to
execute the downstream biological effects [44]. Further studies
are required to clarify the involvement of Notch signaling in
cell cycle-related genes.
Granulosa cells are the principal source of estradiol in
ovarian tissue. Estrogen synthesis is essential for ovarian
cyclicity and fertility and, in addition, estrogens are mitogenic
factors for ovarian granulosa cells [35]. Several works have
described the participation of steroid hormones, mainly
estrogens, in ovarian carcinogenesis [45, 46]. Here, we
observed a decrease in progesterone and estradiol synthesis
in KGN cells when Notch activation was inhibited by DAPT.
However, we cannot discard the possibility that this decrease in
steroid synthesis is due to the lower KGN proliferation and
viability observed in the presence of DAPT or because a direct
action of Notch on the expression of steroidogenic enzymes is
involved.
Notch has also been described as a tumor suppressor and
this is thought to be a result of the crosstalk with other
signaling pathways governing proliferation and apoptosis [13].
Because of the pivotal role of apoptosis in tumorigenesis, we
studied the effect of DAPT on apoptosis parameters in KGN
cells. As we described, DAPT induced the cleavage of PARP
protein in KGN cell culture, indicating an increase in caspase 3
activity.
Furthermore, we demonstrated that this increase in apopto-
sis observed in granulosa tumor cells in the presence of DAPT
is mediated by changes in the levels of the bcl2 family of
proteins as well as in caspase 8 activity. The BAX/BCL2 and
BCLXs/BCLXl proapoptotic ratios were increased when Notch
activation was inhibited, demonstrating an impaired function of
mitochondria in these cells and the participation of the intrinsic
apoptotic pathway in DAPT-induced apoptosis in KGN cells.
The proapoptotic activity of BH3-interacting domain death
agonist (BID) and BAX proteins has been recently confirmed
in KGN cells by using the siRNA technique [47]. BAX
expression has also been associated with apoptosis in ovarian
cancer tissue, and patients expressing high levels of BAX in
tumors have a significantly longer median survival than
patients with low BAX expression [48, 49]. BCL2 is known
to be overexpressed in many solid neoplasms, including
ovarian cancer, contributing to neoplastic transformation and
drug-resistant disease [50, 51]. Moreover, in ovarian cancer,
the percentage and intensity of epithelial and stromal BCL2
staining decreases with tumor progression [52]. In particular,
BCL2 is expressed in human GCTs, suggesting a role of this
antiapoptotic factor in human granulosa cell pathobiology [53,
54]. These antecedents indicate the importance of these
proteins in ovarian cancer development.
Related to pathways involved in DAPT-induced apoptosis
in KGN cells, we also analyzed some members of the death
receptor family. Although we detected no differences in the
levels of the FAS/FASL system, we detected an increase in the
cleavage of caspase 8, indicating an involvement of this
mechanism of apoptosis in KGN cells treated with DAPT.
However, Nishi et al., who established the KGN cell line from
an ovarian carcinoma, described that when these cells are
exposed to FAS antibody with the addition of interferon-c to
induce receptor-mediated cell death, the number of apoptotic
cells increases dramatically [29]. These results demonstrate that
this mechanism is active in these cells, in agreement with the
importance of the FAS/FASL system in the apoptosis of
granulosa cells in primary culture system [55, 56]. Recently, it
has been reported that TRAIL receptors are expressed in a vast
majority of GCTs as well as in primary GCT cultures, and that
this pathway is functional in this type of tumor cells. This
functionality of TRAIL signaling has also been demonstrated
for KGN cells [54]. Nonetheless, in the present study, we did
not analyze other receptor systems like TNF and/or TRAIL,
which also participate in death receptor apoptosis and could be
involved in the DAPT-induced apoptosis in this cell line.
Further studies are required to elucidate the precise role of
these receptor systems in KGN cells.
Different reports have demonstrated the interaction between
Notch signaling and PI3K/AKT pathways. In breast epithelial
cancer cells, Notch signaling induces an autocrine signaling
loop that activates AKT and is necessary for Notch-induced
protection against apoptosis [27]. More recently, Wang et al.
reported that, in prostate cancer cells, the down-regulation of
NOTCH1 leads to the inhibition of cell growth mechanistically
linked to down-regulation of AKT, suggesting that this protein
is a downstream target of NOTCH1 signaling [28]. In addition,
the PI3K/AKT pathway is frequently activated in ovarian
cancer [57, 58]. Here we showed that phosphorylation of AKT
was inhibited in KGN cells treated with the Notch inhibitor
DAPT. The Notch system and AKT pathway interact in
different ways. In cells belonging to a type of acute lympho-
blastic leukemia (T-ALL), inhibition of Notch signaling by a c-
secretase inhibitor increases PTEN expression, resulting in a
decrease in the activation of PI3K/AKT signaling [59]. Also,
the existence of the NOTCH1-PI3K complex has been
demonstrated in primary T cells in vitro, confirming the
physical interaction of these two proteins [60]. A close
relationship between NOTCH1 receptor and PTEN protein
has also been well described in T-ALL leukemia cells by
Palomero et al. [61]. Interestingly, they found that T-ALL-c-
secretase inhibitor-sensitive cells show detectable levels of
PTEN protein, whereas T-ALL-c-secretase inhibitor-resistant
cells show total absence or a marked decrease in this protein.
They concluded that mutational loss of PTEN is associated
with resistance to NOTCH1 inhibition in human T-ALL [61].
In the present work, we observed an increase in PTEN protein
in KGN cells when the Notch pathway was inhibited. Lague et
al. provided powerful evidence about the role of the
dysregulation of the PI3K/AKT pathway in the pathogenesis
of GCTs by means of a Ptenflox/flox, Amhrcre/
þ
mouse model
that developed GCTs [62]. Our results strengthen the
hypothesis of an interaction between PI3K/AKT and Notch
signaling, but further experiments are needed to deeply
investigate this interaction.
In the present study, we provided the first evidence about
the Notch system acting as a survival pathway in a FOXL2-
mutated granulosa tumor cell line (KGN) representative of the
adult form of GCTs. We also showed a differential expression
of some members of this signaling pathway between normal
and KGN cells. However, we cannot discard the action of
DAPT on other c-secretase substrates.
In summary, our results demonstrate that Notch induces
granulosa tumor cell proliferation and decreases apoptosis-
mediated cell death. Also, Notch might be interacting with the
PI3K/AKT signaling pathway, intensifying the survival role of
Notch in this type of tumor.
NOTCH PATHWAY IN A GRANULOSA TUMOR CELL LINE (KGN)
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